RESEARCHER PROFILE

Oskars Kalējs

← Back to Riga Stradiņš University

O

Riga Stradiņš University

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmiasAcute Ischemic Stroke ManagementCardiac pacing and defibrillation studies

Oskars Kalējs works in Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Cardiac electrophysiology and arrhythmias, Acute Ischemic Stroke Management, Cardiac pacing and defibrillation studies. Recorded institutional associations include Pauls Stradiņš Clinical University Hospital, Riga Stradiņš University.

119Publications
16,888Citations
18H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    2016 · 6,425 citations
  2. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    2022 · 3,140 citations
  3. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

    2022 · 3,076 citations
  4. 2018 ESC Guidelines for the diagnosis and management of syncope

    2018 · 1,947 citations
  5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

    2022 · 507 citations
  6. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy

    2025 · 307 citations
  7. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)

    2020 · 235 citations
  8. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

    2017 · 165 citations
  9. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

    2019 · 82 citations
  10. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

    2022 · 72 citations
  11. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    2022 · 71 citations
  12. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    2021 · 55 citations
  13. Role of Endomyocardial Biopsy in Diagnostics of Myocarditis

    2022 · 40 citations
  14. Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders

    2025 · 33 citations
  15. Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry

    2021 · 31 citations
  16. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    2021 · 21 citations
  17. Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

    2019 · 20 citations
  18. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

    2022 · 18 citations
  19. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry

    2022 · 13 citations
  20. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry

    2022 · 10 citations
  21. Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors

    2023 · 10 citations
  22. Model characterizing sports game referees

    2014 · 7 citations
  23. Sinus Rhythm Maintenance After Electrical Cardioversion for Atrial Fibrillation in High-Risk Patients — Comparative Efficacy of Antiarrhythmic Medications

    2021 · 7 citations
  24. A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients

    2021 · 7 citations
  25. Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?

    2019 · 6 citations

← Return to the university profile